ym 022 has been researched along with cholesteryl oleate in 1 studies
| Studies (ym 022) | Trials (ym 022) | Recent Studies (post-2010) (ym 022) | Studies (cholesteryl oleate) | Trials (cholesteryl oleate) | Recent Studies (post-2010) (cholesteryl oleate) |
|---|---|---|---|---|---|
| 65 | 1 | 8 | 291 | 6 | 27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amouroux, G; de Medina, P; Mhamdi, L; Paillasse, MR; Poirot, M; Silvente-Poirot, S | 1 |
1 other study(ies) available for ym 022 and cholesteryl oleate
| Article | Year |
|---|---|
Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion.
Topics: Animals; Benzodiazepines; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholesterol; Cholesterol Esters; Esterification; Hormone Antagonists; Humans; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Neoplasm Invasiveness; NIH 3T3 Cells; Protein Kinase C; Receptor, Cholecystokinin B; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sterol O-Acyltransferase; Transfection | 2009 |